Market Overview

15 Biggest Mid-Day Gainers For Thursday

Share:
  • GlycoMimetics Inc (NASDAQ: GLYC) shares jumped 67.6 percent to $9.00 as the company reported that GMI-1271 has received the FDA Breakthrough therapy designation for adult relapsed/refractory acute myeloid leukemia.
  • athenahealth, Inc (NASDAQ: ATHN) shares surged 16 percent to $123.30 following a 13D filing from Elliott Associates showing a 9.2 percent stake in the company.
  • Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) shares gained 14 percent to $4.31. Leerink Swann upgraded Achillion Pharmaceuticals from Market Perform to Outperform.
  • CytRx Corporation (NASDAQ: CYTR) rose 12.1 percent to $ 0.508. CytRx will present global Phase 3 aldoxorubicin clinical data in patients with soft tissue sarcomas at the 2017 ASCO Annual Meeting.
  • ImmunoGen, Inc. (NASDAQ: IMGN) shares climbed 11.4 percent to $5.27 as the company disclosed promising new clinical data with mirvetuximab soravtansine in ovarian cancer.
  • Veritiv Corp (NYSE: VRTV) gained 9.2 percent to $43.62. Wells Fargo upgraded Veritiv from Market Perform to Outperform.
  • Perry Ellis International, Inc. (NASDAQ: PERY) rose 8.5 percent to $19.66 after the company reported stronger-than-expected Q1 results.
  • Incyte Corporation (NASDAQ: INCY) gained 7.9 percent to $130.02 Incyte disclosed that its IDO1 enzyme inhibitor in combo with Merck's anti-PD-1 therapy is 'well-tolerated and demonstrated durable clinical responses across multiple solid tumors'. The company also announced that first data from combo of epacadostat with Bristol-Myers' opdivo showed that combo is 'well-tolerated and demonstrates promising clinical outcomes in multiple advanced solid tumors.'
  • Pandora Media Inc (NYSE: P) rose 5.3 percent to $9.41. Sirius XM Holdings Inc. (NASDAQ: SIRI) is in talks about bidding for Pandora, according to sources as reported by the New York Post.
  • L Brands Inc (NYSE: LB) gained 5 percent to $50.80 after the company reported upbeat earnings for its first quarter and raised its FY17 outlook.
  • Syndax Pharmaceuticals Inc (NASDAQ: SNDX) shares gained 5 percent to $14.26 after surging 44.62 percent on Wednesday. Syndax issued results from Phase 2 ENCORE 601 trial of entinostat in combo with Merck's KEYTRUDA for the treatment of advanced melanoma.
  • Teladoc Inc (NYSE: TDOC) shares surged 4.9 percent to $28.90. KeyBanc initiated coverage of Teladoc with an Overweight rating.
  • Shire PLC (ADR) (NASDAQ: SHPG) shares rose 4 percent to $189.50 after the company disclosed that its lanadelumab study met primary endpoint.
  • Affimed NV (NASDAQ: AFMD) shares rose 3.4 percent to $2.33. Affimed reported that it will present immune cell engager data at the American Society of Clinical Oncology Annual Meeting and EACR-AACR-SIC Special Conference.
  • Childrens Place Inc (NASDAQ: PLCE) rose 2.6 percent to $114.50 after the company posted upbeat quarterly profit.
 

Related Articles (ACHN + AFMD)

View Comments and Join the Discussion!

Posted-In: Mid-Day MoversNews Intraday Update Analyst Ratings Movers

Latest Ratings

StockFirmActionPT
ESSBMO CapitalUpgrades255.0
MKTXRosenblattMaintains578.0
ESRTBMO CapitalUpgrades
XPEVUBSDowngrades59.0
COHUNeedhamMaintains50.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com